EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk

Ulf Teichgräber iD

CardioVascular and Interventional Radiology · 2023

DOI: 10.1007/s00270-023-03556-1 ↗

Kurz gefasst

Editorial in der Zeitschrift CardioVascular and Interventional Radiology, 2023. Verfasst von Ulf Teichgräber. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germ…. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Angioplasty, Balloon, Peripheral Arterial Disease. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Jena.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The IN.PACT Global real-world study on the treatment of femoropopliteal peripheral artery disease with paclitaxel drug-coated balloon (DCB) angioplasty revealed sustained effectiveness and safety. Freedom from target lesion revascularization (TLR) at 5 years was 69% and freedom from 5-year all-cause mortality was 79% [1]. Whether long-term outcomes in high-risk participants with diabetes or chronic limb-threatening ischemia (CLTI) differ from those without has now been evaluated in a post hoc analysis. Results are presented in this issue of CVIR, by Rei-jnen et al. [2]. Results from the previous IN.PACT SFA randomized controlled trial (RCT) [3] have likely been basis for this research issue. In the total cohort, DCB was superior to standard balloon angioplasty (PTA) (freedom from TLR: 75 and 65%, respectively, p = 0.02). However, with diabetes, a treatment effect that had been demonstrated at 2 years (primary patency) was no longer evident at 5 years (freedom from TLR: 70 and 64%, respectively, p = 0.243). Whether the latter

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, Balloon, CoronaryAngioplasty, BalloonPeripheral Arterial DiseaseHumansPaclitaxelTreatment OutcomeCoated Materials, BiocompatiblePopliteal ArteryFemoral Artery

Substanzen

PaclitaxelCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany. ulf.teichgraeber@med.uni-jena.de.

ORCID-Profile: Ulf Teichgräber

Förderung

  • Universitätsklinikum Jena

Zitieren

APA

Teichgräber, U. (2023). Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-023-03556-1

Vancouver

Teichgräber U. Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk. CardioVascular and Interventional Radiology. 2023. doi:10.1007/s00270-023-03556-1

BibTeX
@article{Teichgrber2023,
  author = {Teichgräber, Ulf},
  title = {Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk},
  journal = {CardioVascular and Interventional Radiology},
  year = {2023},
  doi = {10.1007/s00270-023-03556-1}
}
Kostenlos starten →